Reprogramming Transcription via Distinct Classes of Enhancers Functionally Defined by eRNA
By Dong Wang, Ivan Garcia-Bassets, C. Benner, Wenbo Li, Xue Su, Yiming Zhou, Jinsong Qiu, Wen Liu, M. Kaikkonen, Kenny Ohgi and 3 more. Nature, 2011
848 citations recorded by the source corpus.
Mammalian genomes are populated with thousands of transcriptional enhancers that orchestrate cell-type-specific gene expression programs, but how those enhancers are exploited to institute alternative, signal-dependent transcriptional responses remains poorly understood. Here we present evidence that cell-lineage-specific factors, such as FoxA1, can simultaneously facilitate and restrict key regulated transcription factors, exemplified by the androgen receptor (AR), to act on structurally and functionally distinct classes of enhancer. Consequently, FoxA1 downregulation, an unfavourable prognostic sign in certain advanced prostate tumours, triggers dramatic reprogramming of the hormonal response by causing a massive switch in AR binding to a distinct cohort of pre-established enhancers. These enhancers are functional, as evidenced by the production of enhancer-templated non-coding RNA (eRNA) based on global nuclear run-on sequencing (GRO-seq) analysis, with a unique class apparently requiring no nucleosome remodelling to induce specific enhancer–promoter looping and gene activation. GRO-seq data also suggest that liganded AR induces both transcription initiation and elongation. Together, these findings reveal a large repository of active enhancers that can be dynamically tuned to elicit alternative gene expression programs, which may underlie many sequential gene expression events in development, cell differentiation and disease progression.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5114ab4f6344bcff36490c051e183a2cf3370ae6
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- George A. Calin
- Carlo Maria Croce
- Howard Y. Chang
- Jianhua Yang
- Liang-Hu Qu
- Jeannie T. Lee
- K. Zaret
- Kevin C. Wang
Citations in the corpus
- LncRNA-Dependent Mechanisms of Androgen Receptor-regulated Gene Activation Programs (2013, neutral): “The full-length AR expression vector has been previously described 17 .”
- Pioneer transcription factors: establishing competence for gene expression. (2011, background): “While current studies indicate that long, noncoding RNAs can be associated with specific genomic regions and associated regulatory factors (KC Wang et al. 2011), it remains to be determined whether such RNAs play an initiating role in targeting themselves or transcription factors to DNA.”
- Transcriptional Regulation and its Misregulation in Disease (2013, neutral): “6 eRNAs are generated from active enhancers, thus the number of eRNAs depends on the set of active enhancers in a cell (Kim et al., 2010; Wang et al., 2011).”
- ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data (2012, background): “GSE17611 GSM439776 primary keratinocyte p63 (13) GSM439777 primary keratinocyte p63 (13) GSM538930 primary keratinocyte p63 (13) GSE19235 GSM476650 K562 ZNF263 (14) GSM476651 K562 ZNF263 (14) GSE19013 GSM470418 MCF-7 cells ER (15) GSE12783 GSM320736 HeLa S3 STAT1 (16) GSE21200 GSM518373 embryonic st”
- Long noncoding RNA in prostate, bladder, and kidney cancer. (2014, background): “In PCa cells, bidirectional eRNA production is induced after binding of AR to responsive enhancers, and it is concomitant with sustaining of open chromatin structure and indirect activation of gene expression [22] possibly via the mechanism described above.”
- Latent enhancers activated by stimulation in differentiated cells. (2013, neutral): “FoxA1 was also found to organize the enhancer repertoire of prostate cancer cells, thus directing androgen receptor (AR) recruitment to predefined genomic sites (Wang et al., 2011).”
- Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers (2014, neutral): “This HMM identified a total of ~120K putative TSSs in each cell line, within the range previously reported (80 to 150 K) 8, 10, 26, 27 .”
- Molecular mechanisms of long noncoding RNAs (2011, background): “The recent identification of HOTTIP lncRNA from the human HoxA cluster (described above; Wang et al., 2011b) adds an additional dimension to cis regulation by lncRNAs by defining a central role for chromosome looping in delivering a lncRNA to its site of action.”
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer (2011, result): “While this work was under consideration for publication, similar findings on the role of FoxA1 in reprogramming of the AR pathway in a related prostate cancer cell line (LNCaP cells) was published (Wang et al, 2011).”
- TANRIC: An interactive open platform to explore the function of lncRNAs in cancer (2015, positive): “Emerging evidence has indicated that lncRNAs contribute to tumor initiation and progression through diverse mechanisms ranging from epigenetic regulation of key cancer genes (5, 6) and enhancer-associated activity (7) to posttranscriptional processing of mRNAs (8, 9).”
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. (2016, background): “Loss-of-function studies showed that degradation of eRNA is enough to reduce expression of neighboring genes (162, 211, 282).”
- Landscape of transcription in human cells (2012, neutral): “Almost half (18,330) of the GENCODE (v7) annotated genes detected for all 15 cell lines (35,494) were identified in the analysis of just these three nuclear subcompartments.”
- Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription (2013, background): “Studies indicate that LSD1 directly binds to and is required for the ‘‘decommissioning’’ of embyonic stem cell-specific enhancers during ES cell differentiation by removing the H3K4me1/2 marks (Whyte et al., 2012).”